You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAS mutant

Showing 1 - 25 of 1,163
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022

Colorectal Cancer, Metastatic Colon Cancer Trial (Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab, Placebo + FOLFIRI +

Not yet recruiting
  • Colorectal Cancer
  • Metastatic Colon Cancer
  • Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab
  • Placebo + FOLFIRI + Bevacizumab
  • (no location specified)
Aug 1, 2023

Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

Not yet recruiting
  • Malignant Solid Neoplasm
  • +4 more
  • (no location specified)
Nov 8, 2022

Colorectal Carcinoma, Liver Metastases Trial in Shanghai (mFOLFOXIRI regimen, mFOLFOX regimen, Bevacizumab)

Recruiting
  • Colorectal Carcinoma
  • Liver Metastases
  • mFOLFOXIRI regimen
  • +2 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Sep 22, 2021

Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Singapore (Trametinib, Ruxolitinib)

Recruiting
  • Colorectal Cancer
  • Pancreatic Adenocarcinoma
  • Singapore, Singapore
    National Cancer Centre
Jun 10, 2022

Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)

Recruiting
  • Tumor, Solid
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Nov 30, 2022

Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

Recruiting
  • Advanced Solid Tumor (Phase 1)
  • +4 more
  • Duarte, California
  • +4 more
Feb 2, 2023

Neoadjuvant Treatment, Rectal Cancer, Bevacizumab Trial (Bevacizumab+mFOLFOX6)

Not yet recruiting
  • Neoadjuvant Treatment
  • +3 more
  • (no location specified)
Oct 28, 2021

Colorectal Cancer Trial in Salt Lake City (Cetuximab)

Recruiting
  • Colorectal Cancer
  • Salt Lake City, Utah
  • +1 more
May 3, 2022

Metastatic Colorectal Cancer, RAS Mutation Trial in Hangzhou (sintilimab injection, Control Test)

Recruiting
  • Metastatic Colorectal Cancer
  • RAS Mutation
  • sintilimab injection
  • Control Test
  • Hangzhou, Zhejiang, China
    the Second Affiliated Hospital of Medical College of Zhejiang Un
Apr 19, 2021

Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Recurrent Ovarian Carcinoma
  • Biopsy
  • +5 more
  • (no location specified)
Sep 29, 2022

Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)

Terminated
Has Results
  • Pancreatic Cancer
  • Fayetteville, Arkansas
  • +17 more
Dec 28, 2021

Advanced Colorectal Cancer Trial in Benevento, Napoli, Potenza (regorafenib)

Active, not recruiting
  • Advanced Colorectal Cancer
  • Benevento, Italy
  • +3 more
Mar 3, 2021

Colorectal Cancer Trial in Hangzhou (Surufatinib, Toripalimab, chemo)

Recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Feb 26, 2022

Centralized Tumour Board and Secondary Intervention Rate in mCRC

Not yet recruiting
  • Metastatic Colorectal Cancer
  • +3 more
  • Virtual centralized multidisciplinary tumour board
  • (no location specified)
Apr 15, 2021

Molecular Predictors of Resistance and Response to Regorafenib

Completed
  • Metastatic Colorectal Cancer
  • Carshalton, Surrey, United Kingdom
    The Royal Marsden NHS Foundation Trust London and Surrey
Apr 30, 2021

Rectal Cancer Trial in Australia, New Zealand (TG02-treatment, Pembrolizumab)

Terminated
Has Results
  • Rectal Cancer
  • Brisbane, Australia
  • +3 more
Nov 17, 2021

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
    • (no location specified)
    Aug 23, 2020

    Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

    Completed
    Has Results
    • Solid Tumor
    • Colorectal Cancer
    • Oxford, United Kingdom
      Oxford University Hospital NHS Trust
    Jun 14, 2021

    Colorectal Cancer Stage IV Trial in Hangzhou (IBI308)

    Recruiting
    • Colorectal Cancer Stage IV
    • Hangzhou, State..., China
      Xuefeng Fang
    Dec 16, 2021

    Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766))

    Completed
    • Carcinoma, Hepatocellular
    • Refametinib (BAY86-9766)
    • Washington, District of Columbia
    • +57 more
    Apr 6, 2021

    Metastatic Colorectal Cancer Trial in Worldwide (MEK162, Panitumumab)

    Completed
    Has Results
    • Metastatic Colorectal Cancer
    • Los Angeles, California
    • +7 more
    Jan 27, 2021

    Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766), Sorafenib (BAY43-9006))

    Completed
    • Carcinoma, Hepatocellular
    • Refametinib (BAY86-9766)
    • Sorafenib (BAY43-9006)
    • Louisville, Kentucky
    • +78 more
    Apr 6, 2021

    Colorectal Tumors Trial in Shanghai (avastin, mFOLFOX6)

    Completed
    • Colorectal Neoplasms
    • Shanghai, Shanghai, China
      Zhongshan Hospital, Fudan University
    Dec 15, 2019